DAVID JOHNSON: Open Payments
NPI 1780781302 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,095 in 156 payments from 12 companies in 2025. Trend: 2023 $2,080 · 2024 $1,804 · 2025 $3,095
Food & beverage: $3,010Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 37 | $899 |
| Madrigal Pharmaceuticals | 30 | $517 |
| Phathom Pharmaceuticals, Inc. | 22 | $469 |
| Ardelyx, Inc. | 19 | $317 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $314 |
| ABBVIE INC. | 17 | $234 |
| Alnylam Pharmaceuticals Inc. | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| QOL Medical, LLC | 2 | $49 |
| PFIZER INC. | 2 | $45 |
Products named: TREMFYA, REZDIFFRA, VOQUEZNA, IBSRELA, XIFAXAN, GIVLAARI, MAVYRET, GATTEX.
Industry payments across KY — which companies pay providers there.
